Other languages Amneal Pharmaceuticals, Inc.

Equities

AMRX

US03168L1052

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
6.68 ^USD	-1.47%		+3.57%	+10.05%

May. 22	Amneal Pharmaceuticals Begins Supplying Generic Version of Narcan	DJ
May. 22	Amneal Begins Supplying Over-The-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Amneal Pharmaceuticals Begins Supplying Generic Version of Narcan	May. 22
Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California	May. 22
Amneal to Participate at Upcoming Investor Conference	May. 22
Amneal Begins Supplying Over-The-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California	May. 22
Goldman Sachs Adjusts Amneal Pharmaceuticals Price Target to $8 From $6.25, Maintains Buy Rating	May. 06
Amneal Reports First Quarter 2024 Financial Results	May. 06
Truist Securities Raises Amneal Pharmaceuticals' Price Target to $9 From $7, Maintains Buy Rating	May. 03
Drugmaker Amneal agrees to $270 million U.S. opioid settlement	May. 03
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	May. 03
Transcript : Amneal Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 03, 2024	May. 03
Amneal Pharmaceuticals Q1 Adjusted Earnings, Revenue Climb	May. 03
Amneal Pharmaceuticals : First Quarter 2024 Earnings Presentation	May. 03
(AMRX) AMNEAL PHARMACEUTICALS Forecasts Fiscal Year 2024 EPS Range $0.53 - $0.63	May. 03
Earnings Flash (AMRX) AMNEAL PHARMACEUTICALS Reports Q1 Revenue $659.2M, vs. Street Est of $619M	May. 03
Earnings Flash (AMRX) AMNEAL PHARMACEUTICALS Posts Q1 EPS $0.14, vs. Street Est of $0.09	May. 03
North American Morning Briefing : Apple, Amgen -2-	May. 03
Amneal: Q1 Earnings Snapshot	May. 03
Amneal Reports First Quarter 2024 Financial Results	May. 03
Amneal Pharmaceuticals, Inc. Affirms Earnings Guidance for Full Year 2024	May. 03
Amneal Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Amneal Pharmaceuticals, Inc.

Equities

AMRX

US03168L1052

Other languages

Filters